Song Zhou
Direktor/Vorstandsmitglied bei Taizhou EOC Pharma Co., Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Xiao Ming Zou | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 14 Jahre |
Xu Jing Su | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 Jahre |
Xin Ni | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 14 Jahre |
Hong Yan Wang | F | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 Jahre |
Cui Ping Gu | M | 44 |
Shanghai Jiao Tong University
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 11 Jahre |
Qing Xu | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 Jahre |
Qiang Zhou | M | 58 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 Jahre |
He Ting Li | M | 49 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 12 Jahre |
Huan Yang | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 Jahre |
Ming Yang Yu | M | 60 |
Shanghai Jiao Tong University
| 19 Jahre |
Lei Fu | M | 61 |
Shanghai Jiao Tong University
| 18 Jahre |
Ting Fu | F | 32 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 Jahre |
Miao Jie Chen | F | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 Jahre |
Wen Kong | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 6 Jahre |
Zheng Yao | F | 40 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Xiang Ming Sun | M | 55 |
East China University of Science & Technology
| 13 Jahre |
Cheng Yang | M | 47 |
East China University of Science & Technology
| 6 Jahre |
Tong Ti | M | - |
Shanghai Jiao Tong University
| 7 Jahre |
Li Xu | M | 42 |
Shanghai Jiao Tong University
| 6 Jahre |
Tian Tian Dai | M | 41 |
Shanghai Jiao Tong University
| 6 Jahre |
Le Sheng Chen | M | 51 |
Shanghai Jiao Tong University
| 6 Jahre |
Wen Rui Hou | M | 44 |
Shanghai Jiao Tong University
| 10 Jahre |
Lijia Huang | M | - |
East China University of Science & Technology
| 7 Jahre |
Hai Lin | M | 51 |
Shanghai Jiao Tong University
| 1 Jahre |
Yi Qun Chu | M | 41 |
Shanghai Jiao Tong University
| 1 Jahre |
Cheng Qi Fang | M | 34 |
Shanghai Jiao Tong University
| 4 Jahre |
Da Zhi He | M | 46 |
Shanghai Jiao Tong University
| 3 Jahre |
Wei Peng | M | 38 |
Shanghai Jiao Tong University
| 4 Jahre |
Yu Gao | M | 41 |
Shanghai Jiao Tong University
| 4 Jahre |
Wei Liu | M | 37 |
Shanghai Jiao Tong University
| 5 Jahre |
Zhi Long Zhu | M | 54 |
Shanghai Jiao Tong University
| 3 Jahre |
Guo Xiang Wang | M | 51 |
Shanghai Jiao Tong University
| 3 Jahre |
Hong Yu Zhang | M | 62 |
Shanghai Jiao Tong University
| 2 Jahre |
Yan Song Chang | M | 56 |
Shanghai Jiao Tong University
| 2 Jahre |
Hao Zhang | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Jian Hua Mi | M | 47 |
Shanghai Jiao Tong University
| 3 Jahre |
Jun Wang | M | 38 |
Shanghai Jiao Tong University
| 4 Jahre |
Tian Nian Fu | M | 60 |
Shanghai Jiao Tong University
| 4 Jahre |
Zhang Wan | M | 42 |
Shanghai Jiao Tong University
| 1 Jahre |
Xin Hao He | M | 43 |
Shanghai Jiao Tong University
| 4 Jahre |
Rong Qing Lu | M | 45 |
Shanghai Jiao Tong University
| 1 Jahre |
Ziguang Gao | M | 42 |
Shanghai Jiao Tong University
| 4 Jahre |
Ziyu Shen | M | 40 |
Shanghai Jiao Tong University
| 1 Jahre |
Yuan Wen Xia | M | 40 |
Shanghai Jiao Tong University
| 4 Jahre |
Li Li Tai | F | 42 |
Shanghai Jiao Tong University
| 3 Jahre |
Hong Ping Wu | M | 43 |
Shanghai Jiao Tong University
| 4 Jahre |
En Ci Qu | M | 41 |
Shanghai Jiao Tong University
| 4 Jahre |
Chun Na Zhang | F | 46 |
Shanghai Jiao Tong University
| 1 Jahre |
Jun Yang | M | 52 |
Shanghai Jiao Tong University
| 3 Jahre |
Yinan Peng | M | 42 |
Shanghai Jiao Tong University
| 1 Jahre |
Si Yu Shen | M | 42 |
Shanghai Jiao Tong University
| 4 Jahre |
Jiayi Huang | M | 42 |
Shanghai Jiao Tong University
| 4 Jahre |
Janet Yan Feng | F | 47 |
Shanghai Jiao Tong University
| 1 Jahre |
Lu Zhu Jiang | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Yang Jiao | M | 38 |
Shanghai Jiao Tong University
| 4 Jahre |
Peter Wu | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Yan Lu Huang | M | 52 |
Shanghai Jiao Tong University
| 3 Jahre |
Meng Ya Liu | F | 35 |
Shanghai Jiao Tong University
| 4 Jahre |
Xiu Mei Tao | M | 47 |
Shanghai Jiao Tong University
| 4 Jahre |
Gong You Liu | M | 42 |
Shanghai Jiao Tong University
| 3 Jahre |
Shu Fan Lian | M | 43 |
Shanghai Jiao Tong University
| 2 Jahre |
Wei Wang | M | 41 |
Shanghai Jiao Tong University
| 4 Jahre |
Jin Lai Yu | M | 75 |
Shanghai Jiao Tong University
| 2 Jahre |
Benson He | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Wei Hao | M | 42 |
Shanghai Jiao Tong University
| 4 Jahre |
Doris Shujia Huang | F | - |
Shanghai Jiao Tong University
| 4 Jahre |
Xiang Bin Huang | M | 59 |
Shanghai Jiao Tong University
| 2 Jahre |
Xue Qing Hu | M | 53 |
Shanghai Jiao Tong University
| 3 Jahre |
Feng Yuan Liu | M | 53 |
Shanghai Jiao Tong University
| 3 Jahre |
Hao Zhang | M | 64 |
Shanghai Jiao Tong University
| 2 Jahre |
Yun Jiang | M | 48 |
Shanghai Jiao Tong University
| 4 Jahre |
Yong Jun Shao | M | 49 |
Shanghai Jiao Tong University
| 2 Jahre |
Raymond Feng | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Xiao Dong Liang | M | 47 |
East China University of Science & Technology
| 1 Jahre |
Jin Qiao | M | 40 |
Shanghai Jiao Tong University
| 1 Jahre |
Jian Cao | M | 49 |
Shanghai Jiao Tong University
| 2 Jahre |
Tao Wang | M | 51 |
Shanghai Jiao Tong University
| 3 Jahre |
Guoxin Zhang | M | 60 |
Shanghai Jiao Tong University
| 1 Jahre |
Yong Zhang | M | 52 |
Shanghai Jiao Tong University
| 2 Jahre |
Yi Qing Chen | M | 40 |
Shanghai Jiao Tong University
| 4 Jahre |
Zhen You Zhu | M | 51 |
Shanghai Jiao Tong University
| 3 Jahre |
Teng Ren | M | 37 |
Shanghai Jiao Tong University
| 4 Jahre |
Lei Cao | M | 59 |
Shanghai Jiao Tong University
| 2 Jahre |
Qiang Qin | M | 61 |
Shanghai Jiao Tong University
| 2 Jahre |
Nan Zhang | M | 41 |
Shanghai Jiao Tong University
| 4 Jahre |
Lei Jia | M | 41 |
Shanghai Jiao Tong University
| 4 Jahre |
Kai Sun | M | 38 |
Shanghai Jiao Tong University
| 4 Jahre |
Wen Jin Zhu | F | 49 |
Shanghai Jiao Tong University
| 2 Jahre |
Yi Hu | F | - |
Shanghai Jiao Tong University
| 4 Jahre |
Xi Chen | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Qi Zhu | M | 53 |
Shanghai Jiao Tong University
| 5 Jahre |
Yu Wu | M | 39 |
Shanghai Jiao Tong University
| 4 Jahre |
Xue Rui Fan | M | 36 |
Shanghai Jiao Tong University
| 4 Jahre |
Sheng Wei Bao | M | 40 |
Shanghai Jiao Tong University
| 4 Jahre |
Jian Guo Zhang | M | 63 |
Shanghai Jiao Tong University
| 2 Jahre |
Jia He | M | 70 |
Shanghai Jiao Tong University
| 1 Jahre |
Xin Li | M | 40 |
Shanghai Jiao Tong University
| 4 Jahre |
Qi He | M | - |
Shanghai Jiao Tong University
| 4 Jahre |
Cecilia Chen | F | - |
Shanghai Jiao Tong University
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
China | 99 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen